Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

Yalcin, Suayib; Dane, Faysal; Oksuzoglu, Berna; Yildirim, Nuriye; Isikdogan, Abdurrahman; Ozkan, Metin; Demirag, Guzin; Coskun, Hasan Senol; Karabulut, Bulent; Evrensel, Turkkan; Ustaoglu, Mehmet Ali; Ozdemir, Feyyaz; Turna, Hande; Yavuzsen, Tugba; Aykan, Faruk; Sevinc, Alper; Akbulut, Hakan; Yuce, Deniz; Hayran, Mutlu; Kilickap, Saadettin

Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

Tarih

2018

Yazarlar

Isikdogan, Abdurrahman

Yayıncı

Amer Soc Clinical Oncology

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Açıklama

Gastrointestinal Cancers Symposium -- JAN 18-20, 2018 -- San Francisco, CA

Kaynak

Journal of Clinical Oncology

WoS Q Değeri

Q1

Cilt

36

Sayı

4

Bağlantı

https://doi.org/10.1200/JCO.2018.36.4_suppl.346
https://hdl.handle.net/11454/30692

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu

Detaylı Öğe Kaydı

Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

Tarih

Yazarlar

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Erişim Hakkı

Özet

Açıklama

Anahtar Kelimeler

Kaynak

WoS Q Değeri

Scopus Q Değeri

Cilt

Sayı

Künye

Bağlantı

Koleksiyon